Related Experiment Video

Updated: Oct 21, 2025

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

22.1K

Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2021

Monica M Lahra1,2, Masoud Shoushtari1, Tiffany R Hogan1

  • 1The World Health Organisation Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, New South Wales Health Pathology, Microbiology, The Prince of Wales Hospital, Randwick, NSW, 2031.

Communicable Diseases Intelligence (2018)
|September 9, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.4K
Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

18.5K

Related Experiment Videos

Last Updated: Oct 21, 2025

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

22.1K
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.4K
Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

18.5K

Related Concept Videos

Principles of Disease Surveillance01:26

Principles of Disease Surveillance

258
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
258

Articles linked to this work by shared authors, journal, and citation graph.

Atypical infections caused by pathogenic Neisseria species N. meningitidis and N. gonorrhoeae.

Clinical microbiology reviews·2026

Meningococcal B Vaccine to Prevent Neisseria gonorrhoeae Infection.

The New England journal of medicine·2026

Limitations of Global Surveillance for Neisseria gonorrhoeae Antimicrobial Resistance.

Emerging infectious diseases·2026

Gene exchange between Neisseria meningitidis and Neisseria gonorrhoeae.

Microbial genomics·2026

Determining targets for ceftriaxone resistance detection in Neisseria gonorrhoeae based on genotype-phenotype data: an observational study.

The Lancet. Microbe·2025

WHO global gonococcal antimicrobial surveillance programmes, 2019-22: a retrospective observational study.

The Lancet. Microbe·2025

The first high pathogenicity avian influenza A(H5N1) clade 2.3.4.4b incursions in the Hunter New England region, New South Wales, Australia, June-July 2026.

Communicable diseases intelligence (2018)·2026

ATAGI targeted review 2025: Immunisation considerations for immunocompromised people in Australia.

Communicable diseases intelligence (2018)·2026

Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2026.

Communicable diseases intelligence (2018)·2026

Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2025.

Communicable diseases intelligence (2018)·2026

Early use of genomics to guide acquisition investigation of Salmonella Typhi.

Communicable diseases intelligence (2018)·2026

Report of the National Influenza Surveillance Scheme, 2020-2021.

Communicable diseases intelligence (2018)·2026

Spanish heart transplant registry. 37th official report of the Heart Failure Association of the Spanish Society of Cardiology.

Revista espanola de cardiologia (English ed.)·2026

Scoring architecture and transparency in healthcare accreditation: A scoping review of measurement design and signalling effects.

SAGE open medicine·2026

An annotated dataset of Building Management System periodic alarms.

Data in brief·2026

Designing eligibility and evaluation criteria for antibacterial pull incentives: a comparative review of implemented and emerging initiatives.

The Lancet regional health. Europe·2026

Financial implications of post-transcarotid artery revascularization duplex surveillance.

Seminars in vascular surgery·2026

Reappraisal of the Impact of Institutional Volume on Outcomes After Heart Transplantation.

The Annals of thoracic surgery·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us